241 A Comparison of Lung Cancer Outcome of Two Surgical referral centres from Single District Hospital

Introduction
30% of patients with non-small-cell lung cancer experience recurrence (1). It has been found that up to 24% of patients recur locally following lung cancer surgery. The risk of this increases with the stage of the primary cancer (2). We investigated patient outcomes of lung cancer following lung cancer surgery at two different surgical centres, and the factors influencing outcomes.
Method
We conducted a retrospective analysis of anonymised data of 251 patients who were diagnosed with lung cancer and underwent surgery with curative intent between 2010 and 2019 at two surgical centres. This included patient demographics, patient risk factors, staging, type of surgery, adjuvant treatment, recurrences and death...
Results
Most recurrence was seen after lobectomy in both centres. Comorbidities were similar in both patient groups. The majority of patients had one or more comorbidities. Both hospitals had breaches in achieving the 62 days target of around 50%. The majority of mortality occurred 12–24 months after surgery, and in stage 2–3 patients. In Hospital 1, 33% of those patients that died suffered a recurrence. In Hospital 2, 39% of the patients that died suffered a recurrence...
Conclusions
There was a higher rate of recurrence at Hospital 2 compared to Hospital 1, however, mortality was higher in Hospital 1 than Hospital 2. The demographics and co morbidities in the patient groups may account for this difference. Interestingly, the majority of mortality was not due to recurrence...